Results 1 to 10 of about 1,559,633 (249)

Solid pseudopapillary neoplasm of the pancreas

open access: yesWorld Journal of Hepatology, 2021
Solid pseudopapillary neoplasms are rare. This article reviews the clinical and pathologic features of solid pseudopapillary neoplasm of the pancreas, including the epidemiology, cytology, molecular pathology, differential diagnosis, treatment, and ...
A. Omiyale
semanticscholar   +1 more source

Pancreatic Solid Pseudopapillary Neoplasm: Key Pathologic and Genetic Features.

open access: yesArchives of Pathology & Laboratory Medicine, 2020
CONTEXT.— Solid pseudopapillary neoplasm of the pancreas is a low-grade malignant tumor generally associated with a good prognosis. Solid pseudopapillary neoplasms show peculiar morphologic features, but sometimes the differential diagnosis with other ...
S. Rosa, M. Bongiovanni
semanticscholar   +1 more source

Neuroendocrine neoplasm update: toward universal nomenclature.

open access: yesEndocrine-Related Cancer, 2020
Neuroendocrine neoplasia is described in almost every tissue, either in the pure endocrine organs, the nerve structures or in the so-called diffuse neuroendocrine system. The current nomenclature contains time-honored widely accepted definitions; however,
G. Rindi, F. Inzani
semanticscholar   +1 more source

Sex differences in solid pseudopapillary neoplasm of the pancreas: A population‐based study

open access: yesCancer Medicine, 2020
Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare tumor. This study aims to examine the clinicopathological features and surgical treatments of SPN and compare the clinical behavior and prognosis between men and women with SPN.
Jiali Wu   +6 more
semanticscholar   +1 more source

Tagraxofusp in Blastic Plasmacytoid Dendritic‐Cell Neoplasm

open access: yesNew England Journal of Medicine, 2019
Background Blastic plasmacytoid dendritic‐cell neoplasm (BPDCN) is an aggressive hematologic cancer that is caused by transformed plasmacytoid dendritic cells that overexpress interleukin‐3 receptor subunit alpha (IL3RA or CD123). Tagraxofusp (SL‐401) is
N. Pemmaraju   +17 more
semanticscholar   +1 more source

Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1.

open access: yesJournal of Clinical Oncology, 2019
PURPOSE DICER1 syndrome is an autosomal-dominant, pleiotropic tumor-predisposition disorder caused by pathogenic germline variants in DICER1. We sought to quantify risk, hazard rates, and the probability of neoplasm incidence accounting for competing ...
D. Stewart   +11 more
semanticscholar   +1 more source

An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker

open access: yesBMC Cancer, 2018
Pancreatic cancer is associated with an extremely poor prognosis, so new biomarkers that can detect the initial stages are urgently needed. The significance of serum microRNA (miR) levels in pancreatic neoplasm such as pancreatic cancer and intraductal ...
T. Goto   +18 more
semanticscholar   +1 more source

Risk of Appendiceal Neoplasm in Periappendicular Abscess in Patients Treated With Interval Appendectomy vs Follow-up With Magnetic Resonance Imaging: 1-Year Outcomes of the Peri–Appendicitis Acuta Randomized Clinical Trial

open access: yesJAMA Surgery, 2019
Importance The step after conservative treatment of periappendicular abscess arouses controversy, ranging from recommendations to abandon interval appendectomy based on low recurrence rates of the precipitating diagnosis to performing routine interval ...
Jari Mällinen   +8 more
semanticscholar   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects

open access: yesCancers, 2019
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare tumour, which usually affects elderly males and presents in the skin with frequent involvement of the bone-marrow, peripheral blood and lymph nodes. It has a dismal prognosis, with
M. Sapienza   +9 more
semanticscholar   +1 more source

Blastic plasmacytoid dendritic cell neoplasm

open access: yesClinical Case Reports, 2018
Blastic plasmacytoid dendritic cell neoplasm is an aggressive neoplasm with a median survival of only a few months despite treatment. An exhaustive immunohistochemical workup is required to differentiate it from myeloid sarcoma and extranodal NK/T cell ...
M. Rai   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy